Urinary N-telopeptide levels in multiple myeloma patients, correlation with Tc-99m-sestaMIBI scintigraphy and other biochemical markers of disease activity-Reference-Cited by-同舟云学术

Urinary N-telopeptide levels in multiple myeloma patients, correlation with Tc-99m-sestaMIBI scintigraphy and other biochemical markers of disease activity

Published:2003 Issue:1 Volume:21 Page:17-24
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Alexandrakis M. G.,Kyriakou D. S.,Passam F. H.,Malliaraki N.,Vlachonikolis I. G.,Karkavitsas N.

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference27 articles.

1. Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivo

2. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate

3. Myeloma bone disease

4. Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus on the utility of bone markers in the malignant bone disease setting;Critical Reviews in Oncology/Hematology;2011-12

2. The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group;Leukemia;2010-09-02

3. Biochemical Markers of Bone Remodeling in Multiple Myeloma;Myeloma Bone Disease;2010

4. Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy;Current Cancer Drug Targets;2009-11-01

5. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma;Clinica Chimica Acta;2007-04